1[1]Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res, 1999, 842:92-100. 被引量:1
2[2]Kimelberg HK. Current concepts of brain edama: review of laboratory investigations. J Neurosurg, 1995, 83:1051-1059. 被引量:1
3[3]Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem, 1997, 378:151-160. 被引量:1
4[4]Sato H, Kinoshita T, Takino T, et al. Activation of a recombinant membrane type 1-matrix metalloproteinase(MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.FEBS Lett, 1996, 393:101-104. 被引量:1
5[5]Vecil GG, Larsen PH, Corley SM, et al. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res,2000, 61:212-224. 被引量:1
6[6]Ihara M, Tomimoto H, Kinoshita M, et al. Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J Cereb Blood Flow Metab, 2001, 21:828-834. 被引量:1
7[7]Rosenberg GA, Cunningham LA, Wallace J, et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain:activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res, 2001, 893:104-112. 被引量:1
8[8]Heo JH, Lucero J, Abumiya T, et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab, 1999, 19:624-633. 被引量:1
9[9]Beschorner R, Schluesenner HJ, Nguyen TD, et al. Lesion-associated accumulation of uPAR/CD87-expressing infiltrating granulocytes,activated microglial cells/macrophages and upregulation by endothelial cells following TBI and FCI in humans. Neuropathol Appl Neurobiol, 2000, 26:522-527. 被引量:1
10[10]Ahn MY, Zhang ZG, Tsang W, et al. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice. Brain Res, 1999, 837:169-176. 被引量:1
8Kapural L, Bengez G, Barnett J, et al. Serum S-100β as a possible marker of blood-brain barrier disruption [ J]. Brain Research ,2002, 940 : 102. 被引量:1
9Foereh C, Singer O, Neumann-Haefelin T, et al. Evaluation of serum S100β as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction [ J ]. Arch Neurol, 2005,62 : 1130. 被引量:1
10Warach S, Latour LL. Evidence of reperfusion injury exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption [ J ]. Stroke, 被引量:1